UK Website
JOIN THE CONVERSATION ABOUT
A NEW ANTI-SEIZURE MEDICATION

arrowPrescribing Information and Adverse Event Reporting

The ONTOZRY® Live Forum* – On demand

The ONTOZRY® Live Forum webinars introduced healthcare professionals across the UK to a new treatment option for adult patients with drug-resistant focal-onset seizures.

Epileptologists, Neurologists and Epilepsy Specialist Nurses joined to hear our expert panels discuss the current management of drug-resistant epilepsy as well as the latest ONTOZRY® data. The panels were led by Dr Rhys Thomas, Prof. Ley Sander and Consultant Epilepsy Specialist Nurse Phil Tittensor, who each added their valuable opinion on what the arrival of ONTOZRY® could mean for eligible patients.

If you were unable to attend a webinar, or want a refresh on what you heard, you can now watch the session recap videos below, which are split into three core sections.

TREATING DRUG RESISTANT EPILEPSY: WHERE ARE WE NOW?

Presented by Dr Rhys Thomas (The Evening Session)

ONTOZRY® CLINICAL PROGRAMME AND DATA

Presented by Dr Shanika Samarasekera (The Evening Session)

ONTOZRY® PRACTICAL GUIDANCE

Presented by Sasha Monaghan (The ESN Session)

Reference:

1. ONTOZRY® Summary of Product Characteristics.

*This event was developed and funded by Arvelle Therapeutics (part of Angelini Pharma Company) for UK Healthcare Professionals.

UK11412P | April 2022

Feedback